(Date:11/5/2009)...wire-FirstCall/ -- BioSpecifics Technologies Corp....eloping first-in-class collagenase-based products,...rd quarter ended September 30, 2009. ,, "We we..., the FDA,s Arthritis Advisory Committee unanimous... XIAFLEX(TM) for the treatment of Dupuytren,s dise...
(Date:11/5/2009)...9 Senomyx, Inc. (Nasdaq:...aste receptor-based technologies to discover novel...gredient supply industries, today provided a corpo... third quarter ended September 30, 2009. Revenues...compared to $4.0 million for the third quarter of ...
(Date:11/5/2009).... 5 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone,Co..."Company") today announced,that the Company plans ...,Monday, November 9, 2009, after the market closes...ll at 5:00 pm ET on November 9, 2009,to discuss th...e call by,dialing 1-888-713-4211 or 1-617-213-4864...
(Date:11/5/2009)...ders brings a new look to Pro Repro , ...- Professional Reprographics, Orange County’... to present Brooke Sanders to the company. Brooke ... The addition of Brooke to the company represents ...l Reprographics., , ,Brooke brings with her over f...
Breaking Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14BMP Sunstone to Report Third Quarter 2009 Financial Results 2...on (Nasdaq: DNDN ) announced today the closing o...ring of 10,700,000 shares of its common stock, whi...19.20 per share. On May 8, 2009, Deutsche Bank Se...ing, exercised in full its over-allotment option t...n stock at the public offering price of $19.20 per...
...A has approved an,Investigational New Drug (IND) a... phase I clinical study with its selective PLK-1 s...r. PLK-1 is a mitotic kinase required for,the prol...ally bioavailable,highly efficient and well tolera... dosing. This unique inhibitor adds another promis...
...nc. (Xennex) announced today a major leap for Gene...ilable at http://www.genecards.org/v3 . , , ...ntly upgraded infrastructure, including a comprehe... sophisticated and speedier search engine. It prov...rgeted queries, a user-friendly display and clear ...
Other Biology Technology:Dendreon Announces Closing of Common Stock Offering 2Dendreon Announces Closing of Common Stock Offering 3Nerviano Medical Sciences Receives Approval From the FDA to Enter Phase I Clinical Trials for Their Polo Like Kinase (PLK) Inhibitor 2GeneCards(R) Version 3.0 Beta Released 2GeneCards(R) Version 3.0 Beta Released 3(Date:11/4/2009)... 20 Quest Diagnostics In...ider of diagnostic testing, information and servic...tember 30, 2009, income from continuing operations... from $160 million, or $0.81 per diluted share, fo...r results were reduced by a $0.03 per share charge...
(Date:11/4/2009).... 20 Aware, Inc. (Nasdaq...ogy and biometrics software, today reported financ... 30, 2009. ,, Michael Tzannes, Aware,s Chairm...ay, we announced an agreement to sell our DSL and ...less semiconductor company being spun out of Infin...
(Date:11/4/2009)...ct. 23 GenVault Corporation, the l...for genomic discovery, medicine and identification...lt,s President and CEO, will be presenting at the ... 26th and 27th in La Jolla, CA. ,, During the p...f the company together with recent customer, techn...
Breaking Biology News(10 mins):Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 1Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 2Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 3Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 4GENova gains access to Big Pharma 57148 1GENova gains access to Big Pharma 57148 2GENova gains access to Big Pharma 57148 3Frost 26 Sullivan 3A First Responders Communication Interoperability A Vital Need for Life Saving Services 57146 1Frost 26 Sullivan 3A First Responders Communication Interoperability A Vital Need for Life Saving Services 57146 2...f the words "parasitic worms," it,s a fact that so...At Michigan State University, researcher Linda Man...vestigating the role that parasites can play in tr...ns. , Her research is part of a more than $10 mil...g the Food and Waterborne Diseases Integrated Rese...
...enomes (IMG) data management system of the U.S. De...) has been released to the public. IMG 1.5 now con...chaeal, 15 eukaryotic genomes and 259 bacterial ph...genomes. , IMG 1.5 contains 62 finished and 100 ...total to 162 microbial genomes generated in-house....
...eloped a new low-cost system that analyzes scatter...plications in medicine, food processing and homela...technologies. , The technique - Bacteria Rapid De...s by shining a laser through a petri dish containi.... , "Unlike conventional methods, we don,t have ...
Other Biology News:Parasitic worms used to fight bowel disease 2DOE JGI releases IMG 1.5 with curated archaeal genomes 2Purdue creates new low-cost system to detect bacteria 2Purdue creates new low-cost system to detect bacteria 3Purdue creates new low-cost system to detect bacteria 4MUTAN SUPER EXPRESS KM 20 RXN from Takara Mirus Bio
...omics Analyzer Mass Standards Kit includes reagent...timize instrument parameters, and calibrate the ma...s designed for use with the 4700 Proteomics Analyz...dards in the kit require minimal preparation and w...
Adaptor BamH I-Sma I from Takara Mirus Bio
Adaptor EcoR I Sma I from Takara Mirus Bio
Biology Products: